US2003212136A1PendingUtilityA1
Creatine ester pronutrient compounds and formulations
Priority: Sep 14, 2001Filed: Sep 14, 2001Published: Nov 13, 2003
Est. expirySep 14, 2021(expired)· nominal 20-yr term from priority
A61P 9/00A61P 25/16A61P 25/00A61P 3/02A61K 31/22A61K 31/7004A61P 21/00A23V 2002/00A23L 33/10A61K 31/221A61K 31/198A23K 20/142A61K 31/66
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention describes a method for providing creatine to an animal which includes receiving a creatine ester by the animal. The creatine ester is suitable for being modified by the animal to form creatine.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for providing creatine to an animal, comprising:
receiving a creatine ester by the animal, wherein the creatine ester is suitable for being modified by the animal to form creatine.
2 . The method as described in claim 1 , wherein the creatine ester is suitable for being formed in a solid form capable of being ingested by the animal.
3 . The method as described in claim 2 , wherein the solid form includes the creatine ester and at least one of dextrose and phosphate.
4 . The method as described in claim 2 , wherein the solid form is configured as at least one of a tablet and a capsule.
5 . The method as described in claim 1 , wherein the creatine ester is suitable for liquid delivery.
6 . The method as described in claim 5 , wherein the creatine ester includes at least one of an aqueous solution and emulsion.
7 . The method as described in claim 1 , wherein the creatine ester includes at least one of creatine ethyl ester, creatine benzyl ester, creatine phosphoester, monocreatine glycerol, t-butyl creatine ester, dicreatine glycerol and tricreatine glycerol.
8 . The method as described in claim 1 , wherein the creatine ester is received by the animal, the creatine ester is modified by the animal into creatine and an alcohol.
9 . The method as described in claim 8 , wherein the creatine ester is modified by the animal into creatine and alcohol by an esterase.
10 . The method as described in claim 8 , wherein the creatine ester is modified by at least one of an intestinal lumen, epithelial cell and blood of the animal into creatine.
11 . The method as described in claim 1 , further comprising forming a creatine ester, wherein an acid moiety of creatine is modified to provide an ester bond.
12 . The method as described in claim 1 , wherein the animal includes a human and livestock.
13 . A food supplement, comprising:
a creatine ester suitable for being modified by an animal to form creatine.
14 . The food supplement as described in claim 13 , wherein the creatine ester is suitable for being formed in a solid form capable of being ingested by the animal.
15 . The food supplement as described in claim 14 , wherein the solid form includes the creatine ester and at least one of dextrose and phosphate.
16 . The food supplement as described in claim 14 , wherein the solid form is configured as at least one of a tablet and a capsule.
17 . The food supplement as described in claim 13 , wherein the creatine ester is suitable for liquid delivery.
18 . The food supplement as described in claim 17 , wherein the creatine ester includes at least one of an aqueous solution and emulsion.
19 . The food supplement as described in claim 13 , wherein the creatine ester includes at least one of creatine ethyl ester, creatine benzyl ester, creatine phosphoester, monocreatine glycerol, t-butyl creatine ester, dicreatine glycerol and tricreatine glycerol.
20 . The food supplement as described in claim 13 , wherein the creatine ester is received by the animal, the creatine ester is modified by the animal into creatine and an alcohol.
21 . The food supplement as described in claim 20 , wherein the creatine ester is modified by the animal into creatine and alcohol by an esterase.
22 . The food supplement as described in claim 20 , wherein the creatine ester is modified by at least one of an intestinal lumen, epithelial cell and blood of the animal into creatine.
23 . The food supplement as described in claim 13 , further comprising forming a creatine ester, wherein an acid moiety of creatine is modified to provide an ester bond.
24 . The food supplement as described in claim 13 , wherein the animal includes at least one of human and livestock.
25 . A method for providing creatine to an animal, comprising:
receiving an ester derivative of creatine by the animal, wherein the ester derivative of creatine is suitable for acting as a pronutrient in an animal.
26 . The method as described in claim 25 , wherein the ester derivative of creatine acts as a pronutrient in the gastrointestinal tract of the animal.
27 . The method as described in claim 25 , wherein the pronutrient is metabolized by the animal to form creatine.
28 . The method as described in claim 27 , wherein the pronutrient is metabolized by an esterase.
29 . The method as described in claim 28 , wherein the pronutrient is metabolized by esterases in at least one of an intestinal lumen, epithelial cell and blood.
30 . The method as described in claim 25 , wherein the pronutrient is metabolized by the animal for form an alcohol.
31 . The method as described in claim 25 , wherein the creatine ester is suitable for being formed in a solid form capable of being ingested by the animal.
32 . The method as described in claim 31 , wherein the solid form includes the creatine ester and at least one of dextrose and phosphate.
33 . The method as described in claim 31 , wherein the solid form is configured as at least one of a tablet and a capsule.
34 . The method as described in claim 25 , wherein the creatine ester is suitable for liquid delivery.
35 . The method as described in claim 34 , wherein the creatine ester includes at least one of an aqueous solution and emulsion.
36 . The method as described in claim 25 , wherein the creatine ester includes at least one of creatine ethyl ester, creatine benzyl ester, creatine phosphoester, monocreatine glycerol, t-butyl creatine ester, dicreatine glycerol and tricreatine glycerol.
37 . The method as described in claim 25 , wherein the creatine ester is received by the animal, the creatine ester is modified by the animal into creatine and an alcohol.
38 . The method as described in claim 37 , wherein the creatine ester is modified by the animal into creatine and alcohol by an esterase.
39 . The method as described in claim 37 , wherein the creatine ester is modified by at least one of an intestinal lumen, epithelial cell and blood of the animal into creatine.
40 . The method as described in claim 25 , further comprising forming a creatine ester, wherein an acid moiety of creatine is modified to provide an ester bond.
41 . The method as described in claim 25 , wherein the animal includes human and livestock.
42 . A composition of matter, comprising:
wherein R represents an ester.
43 . The composition of matter as described in claim 42 , wherein R represents an ester so as to form a composition of matter including at least one of creatine benzyl ester, creatine phosphoester, monocreatine glycerol, t-butyl creatine ester, dicreatine glycerol and tricreatine glycerol.
44 . The composition of matter as described in claim 42 , wherein the composition of matter is suitable for being converted to creatine upon receipt by an animal.
45 . The composition of matter as described in claim 44 , wherein upon receipt of the composition of matter by the animal, creatine and an alcohol are formed.
46 . The composition of matter as described in claim 42 , wherein a salt is formed of the composition of matter.
47 . A method of producing a creatine pronutrient, comprising:
reacting at least one of an anhydrous creatine and hydrated form of creatine with an alcohol in an acidic environment, wherein a product is formed including a creatine ester pronutrient.
48 . The method as described in claim 47 , wherein the hydrated form of creatine includes creatine monohydrate.
49 . The method as described in claim 47 , wherein the alcohol includes at least one of ethyl alcohol and benzyl alcohol.
50 . The method as described in claim 47 , wherein the acidic environment is achieved through hydrochloric acid being present.
51 . The method as described in claim 47 , further comprising purifying the product.
52 . The method as described in claim 51 , wherein the product is purified by solvating the product in an alcohol and then cooling to form purified creatine ester.Join the waitlist — get patent alerts
Track US2003212136A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.